Study Shows History of Venous Thromboembolism Causes Increased Risk of Thrombosis Following Cancer Treatment
source: pixabay.com

Study Shows History of Venous Thromboembolism Causes Increased Risk of Thrombosis Following Cancer Treatment

A recent study has found that there is an increased risk of developing recurring thrombosis for cancer patients who have a history of venous thromboembolism, or VTE. The results of…

Continue Reading Study Shows History of Venous Thromboembolism Causes Increased Risk of Thrombosis Following Cancer Treatment

Sabatolimab Can Be Added Safely to Hypomethylating Agents in the Treatment of MDS and AML

Dr. Andrew Brunner, an oncologist at Massachusetts Cancer Center was recently interviewed by Targeted Oncology. The discussion centered around a phase 1b clinical trial (NCT03066648) investigating sabatolimab together with hypomethylating…

Continue Reading Sabatolimab Can Be Added Safely to Hypomethylating Agents in the Treatment of MDS and AML
Rare Classroom: Fabry Disease
source: shutterstock

Rare Classroom: Fabry Disease

Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on some of the rarest, most…

Continue Reading Rare Classroom: Fabry Disease